Market Capitalization (Millions $) |
75 |
Shares
Outstanding (Millions) |
22 |
Employees |
114 |
Revenues (TTM) (Millions $) |
160 |
Net Income (TTM) (Millions $) |
-234 |
Cash Flow (TTM) (Millions $) |
-62 |
Capital Exp. (TTM) (Millions $) |
1 |
Agenus Inc
Agenus Inc. is a biotechnology company based in Lexington, Massachusetts. The company is focused on the discovery, development, and commercialization of immune-based therapies for the treatment of cancer and other diseases. Agenus utilizes its proprietary technologies to develop novel antibodies, vaccines, and adjuvants to activate the immune system against cancer cells. The company's product pipeline includes both clinical and pre-clinical stage candidates targeting various types of cancer. Agenus also collaborates with other pharmaceutical companies to advance its immunotherapy programs.
Company Address: 3 Forbes Road Lexington 2421 MA
Company Phone Number: 674-4400 Stock Exchange / Ticker: NASDAQ AGEN
|